ArticleJournal of gastrointestinal oncology2026

Anlotinib and penpulimab in advanced hepatocellular carcinoma: a new contender emerges.

Oluseyi Abidoye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.